碳离子放疗根治性部分乳腺照射治疗I期乳腺癌的临床研究
本研究纳入14例因身体或精神原因不适合手术的未治疗I期乳腺癌患者,接受碳离子放疗,总剂量从52.8 Gy(RBE)递增至60.0 Gy(RBE),每周四次。中位随访61个月,除10例1级急性皮肤反应外未观察到不良反应,13例维持完全缓解且美容效果优良,1例高级别病例出现局部复发。
要点
- 碳离子放疗对不适合手术的I期乳腺癌患者有效且安全。
- 肿瘤消失时间较长,1例3个月、3例6个月、4例12个月、5例24个月。
- 14例中13例维持完全缓解,美容效果优良。
核心结论
- 碳离子放疗在仔细选择的不适合手术的I期乳腺癌患者中被认为是有效和安全的,建议进一步研究。
研究设计与样本
- 照射体积定义为包括导管内成分的大体肿瘤,初始剂量递增研究为每周四次总52.8 Gy(RBE),确认不良反应可接受后总剂量增至60.0 Gy(RBE)。
主要发现
- 中位随访61个月,除10例1级急性皮肤反应外未观察到不良反应。
- 碳离子放疗至肿瘤消失的时间:1例3个月,3例6个月,4例12个月,5例24个月。
- 第3例在放疗后6个月出现局部复发。
- 12例luminal亚型患者接受5年内分泌治疗。
- 14例肿瘤中13例维持完全缓解且美容效果优良。
关键数值与推荐
- 总剂量从52.8 Gy(RBE)递增至60.0 Gy(RBE),每周四次。
临床怎么用
- 对于因身体或精神原因不适合手术的I期乳腺癌患者,可考虑碳离子放疗,但需仔细选择患者。
局限性
- 样本量小(14例),且仅纳入不适合手术的患者,随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Our institute initiated carbon ion radiotherapy research for patients with stage I breast cancer in April 2013. The purpose of this article is to evaluate the treatment outcome of cases treated outside clinical trial up to May 2020. MATERIALS AND METHODS: Eligibility criteria of the patients were having untreated stage I breast cancer and being unsuitable for operation for physical or mental reasons. The irradiated volume was defined as the gross tumor including intraductal components. The dose escalation study was initially conducted four times a week for a total of 52.8 Gy [relative biological efficacy (RBE)]. After confirming that adverse effects were within acceptable range, the total dose was increased to 60.0 Gy (RBE). RESULTS: Between April 2013 and November 2015, 14 cases were treated. The median follow up period was 61 months. No adverse toxicities were observed except for grade 1 acute skin reaction in 10 cases. The time required from carbonion radiotherapy to tumor disappearance was 3 months in 1 case, 6 months in 3 cases, 12 months in 4 cases, and 24 months in 5 cases. The third case developed local recurrence 6 months after radiotherapy. Twelve patients with luminal subtype received 5-year endocrine therapy. Thirteen of 14 tumors have been maintaining complete response with excellent cosmetic results. CONCLUSIONS: The time from carbon ion radiotherapy to tumor disappearance was longer than expected, but complete tumor disappearance was observed except for one high-grade case. With careful patient selection, carbonion radiotherapy in patients with stage I breast cancer is deemed effective and safe, and further research is recommended.
引用
- Karasawa K, Omatsu T, Shiba S, et al. A clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy. Radiat Oncol. 2020. PMID: 33187529. doi:10.1186/s13014-020-01713-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。